A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
Active, not recruiting · NCT03791112 · Registry updated 2025-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor | Advanced Solid Cancer | Active, not recruiting | Phase 1 | 2025-01-27 | NCT03791112 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Betta Pharmaceuticals Co., Ltd. | 20 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Betta Pharmaceuticals Co. | Hangzhou | China | 1 |